After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of ORIC Pharmaceuticals Inc is $599.82M. A total of 0.55 million shares were traded on the day, compared to an average of 421.80K shares.
In the most recent transaction, Piscitelli Dominic sold 8,851 shares of ORIC for 8.28 per share on Dec 16 ’24. After the transaction, the Chief Financial Officer now owns 106,764 company shares. In a previous transaction on Dec 16 ’24, Multani Pratik S sold 8,850 shares at 8.28 per share. ORIC shares that Chief Medical Officer owns now total 46,765.
Among the insiders who sold shares, Chacko Jacob disposed of 24,660 shares on Dec 16 ’24 at a per-share price of $8.28. This resulted in the PRESIDENT AND CEO holding 778,648 shares of ORIC after the transaction. In another insider transaction, Multani Pratik S bought 8,850 shares at $8.28 per share on Dec 16 ’24.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ORIC has a high of $16.65 and a low of $6.33.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ORIC’s latest balance sheet shows that the firm has $236.98M in Cash & Short Term Investments as of fiscal 2021. There were $1.93M in debt and $15.15M in liabilities at the time. Its Book Value Per Share was $3.88, while its Total Shareholder’s Equity was $272.98M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ORIC is Buy with a score of 5.00.
